This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid014A
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid014A.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org





{{tp|p=32654005|t=2020. Improving the care of older patients during the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32666026|t=2020. Expert consensus on protocol of rehabilitation for COVID-19 patients using framework and approaches of WHO International Family Classifications.|pdf=|usr=}}
{{tp|p=32712236|t=2020. Propofol in COVID 19 - From basic science to clinical impact.|pdf=|usr=}}
{{tp|p=32713604|t=2020. Consistency and reliability of COVID-19 projection models as a means to save lives.|pdf=|usr=}}
{{tp|p=32657818|t=2020. The Down Side of Prone Positioning: The Case of a COVID-19 Survivor.|pdf=|usr=}}
{{tp|p=32659455|t=2020. No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32628134|t=2020. Evaluation and follow-up of pediatric COVID-19 in terms of cardiac involvement: A scientific statement from the Association of Turkish Pediatric Cardiology and Pediatric Cardiac Surgery.|pdf=|usr=}}
{{tp|p=32675641|t=2020. In Response: The Use of Analgesia and Sedation in Mechanically Ventilated Patients with COVID-19 ARDS.|pdf=|usr=}}
{{tp|p=32692228|t=2020. Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19.|pdf=|usr=}}
{{tp|p=32687823|t=2020. Extracorporeal Membrane Oxygenation Support in Severe COVID-19.|pdf=|usr=}}
{{tp|p=32682580|t=2020. Mechanical Risks of Ventilator Sharing in the COVID-19 Era: A Simulation-Based Study.|pdf=|usr=}}
{{tp|p=32654852|t=2020. Biologic Therapy in COVID-19.|pdf=|usr=}}
{{tp|p=32691074|t=2020. A putative AOP for pneumonia related to COVID-19.|pdf=|usr=}}
{{tp|p=32695275|t=2020. COVID-19 and Medical Biotechnology.|pdf=|usr=}}
{{tp|p=32665967|t=2020. Machine learning to assist clinical decision-making during the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32689937|t=2020. Management of Respiratory Distress Syndrome due to COVID-19 infection.|pdf=|usr=}}
{{tp|p=32664944|t=2020. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.|pdf=|usr=}}
{{tp|p=32694132|t=2020. Update to living systematic review on prediction models for diagnosis and prognosis of covid-19.|pdf=|usr=}}
{{tp|p=32682550|t=2020. Interdependence between elevated intra-abdominal, pleural, and airway opening pressure in severe acute respiratory distress syndrome with extracorporeal membrane oxygenation.|pdf=|usr=}}
{{tp|p=32680606|t=2020. Airway management lessons from case reports of negative outcomes. Comment on Br J Anaesth; 125: e168-70.|pdf=|usr=}}
{{tp|p=32698378|t=2020. COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives.|pdf=|usr=}}
{{tp|p=32713829|t=2020. Management of COVID-19 in burns patients: The experience of a UK burn centre.|pdf=|usr=}}
{{tp|p=32712309|t=2020. The Basics of ARDS Mechanical Ventilatory Care for Cardiovascular Specialists.|pdf=|usr=}}
{{tp|p=32681847|t=2020. "How I Do It: High Flow, Non-invasive ventilation and Awake (non-intubation) Proning in Covid-19 Patients with Respiratory Failure".|pdf=|usr=}}
{{tp|p=32679237|t=2020. Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment.|pdf=|usr=}}
{{tp|p=32680896|t=2020. Evaluation and management of shock in patients with COVID-19.|pdf=|usr=}}
{{tp|p=32683854|t=2020. COVID-19: challenges and opportunities.|pdf=|usr=}}
{{tp|p=32683801|t=2020. Overview of Management of Children with COVID-19.|pdf=|usr=}}
{{tp|p=32664708|t=2020. COVID-19 in children: reasons for uneventful clinical course.|pdf=|usr=}}
{{tp|p=32675168|t=2020. NEWS2 system requires modification to identify deteriorating patients with COVID-19.|pdf=|usr=}}
{{tp|p=32675139|t=2020. Research in brief: Prone positioning in COVID-19: What's the evidence.|pdf=|usr=}}
{{tp|p=32622952|t=2020. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.|pdf=|usr=}}
{{tp|p=32688137|t=2020. Non Pharmaceutical Interventions for Optimal Control of COVID-19.|pdf=|usr=}}
{{tp|p=32700405|t=2020. Initiation of Antiviral Treatment in SARS-CoV2: Modeling Viral Dynamics and Drug Properties.|pdf=|usr=}}
{{tp|p=32684170|t=2020. Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance.|pdf=|usr=}}
{{tp|p=32678040|t=2020. Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study.|pdf=|usr=}}
{{tp|p=32665007|t=2020. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome.|pdf=|usr=}}
{{tp|p=32659695|t=2020. Data mining and analysis of scientific research data records on Covid-19 mortality, immunity, and vaccine development - In the first wave of the Covid-19 pandemic.|pdf=|usr=}}
{{tp|p=32691020|t=2020. A novel scoring system in mortality prediction of severe patients with COVID-19.|pdf=|usr=}}
{{tp|p=32685437|t=2020. Proning reduces ventilation heterogeneity in patients with elevated BMI: implications for COVID-19 pneumonia management?|pdf=|usr=}}
{{tp|p=32665949|t=2020. COVID-19 necrotising pneumonia and extracorporeal membrane oxygenation: a challenge for anticoagulation.|pdf=|usr=}}
{{tp|p=32620500|t=2020. First comes the A, then the B: what we learned from the COVID-19 outbreak.|pdf=|usr=}}
{{tp|p=32665174|t=2020. Published evidence on COVID-19 in top-ranked journals: A descriptive study.|pdf=|usr=}}
{{tp|p=32693298|t=2020. COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus.|pdf=|usr=}}
{{tp|p=32682788|t=2020. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.|pdf=|usr=}}
{{tp|p=32703773|t=2020. COVID-19 prediction models should adhere to methodological and reporting standards.|pdf=|usr=}}
{{tp|p=32675213|t=2020. Awake Prone Positioning for Non-intubated Oxygen Dependent COVID-19 Pneumonia Patients.|pdf=|usr=}}
{{tp|p=32675212|t=2020. COVID-19 conundrum: Clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness.|pdf=|usr=}}
{{tp|p=32675205|t=2020. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study.|pdf=|usr=}}
{{tp|p=32482788|t=2020. The perils of premature phenotyping in COVID-19: a call for caution.|pdf=|usr=}}
{{tp|p=32430433|t=2020. A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019.|pdf=|usr=}}
{{tp|p=32661338|t=2020. Comment on: "Care for critically ill patients with COVID-19: don't forget the eyes".|pdf=|usr=}}
{{tp|p=32714921|t=2020. From Farm to Finger Prick-A Perspective on How Plants Can Help in the Fight Against COVID-19.|pdf=|usr=}}
{{tp|p=32700145|t=2020. COVID-19 in Different Age Groups of Children: Initial Impression from Integrated Disease Surveillance Programme (IDSP) under National Centre for Disease Control (NCDC).|pdf=|usr=}}
{{tp|p=32651306|t=2020. Epidemiology and Clinical Features of Coronavirus Disease 2019 in Moroccan Children.|pdf=|usr=}}
{{tp|p=32708196|t=2020. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.|pdf=|usr=}}
{{tp|p=32708112|t=2020. COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis.|pdf=|usr=}}
{{tp|p=32710146|t=2020. Integrating the evidence: confronting the COVID-19 elephant.|pdf=|usr=}}
{{tp|p=32710161|t=2020. Therapie schwerer COVID-19-Verlaufe in der Intensivmedizin.|pdf=|usr=}}
{{tp|p=32705298|t=2020. Die Virologie von SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32710975|t=2020. Interleukin-6-based mortality risk model for hospitalised COVID-19 patients.|pdf=|usr=}}
{{tp|p=32705880|t=2020. No protocol and no liability: a call for COVID crisis guidelines that protect vulnerable populations.|pdf=|usr=}}
{{tp|p=32720239|t=2020. Primary Care Population Management for COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32717144|t=2020. Cultivating a Better Understanding of COVID-19 Amidst a Shifting Landscape.|pdf=|usr=}}
{{tp|p=32685980|t=2020. Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients.|pdf=|usr=}}
{{tp|p=32685975|t=2020. RE: EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED-UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS.|pdf=|usr=}}
{{tp|p=32685969|t=2020. Commentary: Comment on "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis".|pdf=|usr=}}
{{tp|p=32685966|t=2020. Response to: "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients" and "Re: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis".|pdf=|usr=}}
{{tp|p=32685962|t=2020. Response to: Comment on "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients That Should be Ramped-Up Immediately as Key to the Pandemic Crisis".|pdf=|usr=}}
{{tp|p=32687760|t=2020. Recommendations for caring for patients with severe and nonsevere COVID-19.|pdf=|usr=}}
{{tp|p=32669360|t=2020. COVID-19: minimising contaminated aerosol spreading during CPAP treatment.|pdf=|usr=}}
{{tp|p=32657601|t=2020. SARS-CoV-2; What We Know so far.|pdf=|usr=}}
{{tp|p=32701627|t=2020. Specific considerations for venovenous-extracorporeal membrane oxygenation during Coronavirus Disease-2019 pandemic.|pdf=|usr=}}
{{tp|p=32715659|t=2020. Coronavirus disease 2019 pandemic and identifying insufflators with desufflation mode and surgical smoke evacuators for safe CO2 removal.|pdf=|usr=}}
{{tp|p=32680422|t=2020. Comprehensive Review on Current Interventions, Diagnostic, and Nanotechnology Perspectives against SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32690476|t=2020. Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool.|pdf=|usr=}}
{{tp|p=32665317|t=2020. Covid-19: What do we know about "long covid"?|pdf=|usr=}}
{{tp|p=32654267|t=2020. The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy.|pdf=|usr=}}
{{tp|p=32628752|t=2020. Simple 'Rule-of-6' predicts severe COVID-19 disease.|pdf=|usr=}}
{{tp|p=32674129|t=2020. Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality.|pdf=|usr=}}
{{tp|p=32651959|t=2020. Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions.|pdf=|usr=}}
{{tp|p=32693757|t=2020. A Case Study: Analysis of Patents of Coronaviruses and Covid-19 for Technology Assesment and Future Research.|pdf=|usr=}}
{{tp|p=32660401|t=2020. COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy|pdf=|usr=}}
{{tp|p=32651978|t=2020. COVID-19: making the right diagnosis.|pdf=|usr=}}
{{tp|p=32713542|t=2020. Emerging pathogens and COVID-19: A brief introduction.|pdf=|usr=}}
{{tp|p=32713387|t=2020. Prone Positioning in Non-intubated Patients with COVID-19 Outside the Intensive Care Unit: More Evidence Needed.|pdf=|usr=}}
{{tp|p=32716648|t=2020. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.|pdf=|usr=}}
{{tp|p=32651176|t=2020. Evidence-based medicine and COVID-19: what to believe and when to change.|pdf=|usr=}}
{{tp|p=32703036|t=2020. Integrative role of traditional and modern technologies to combat COVID-19.|pdf=|usr=}}
{{tp|p=32674622|t=2020. Emerging technologies for diagnostics and drug delivery in the fight against COVID-19 and other pandemics.|pdf=|usr=}}
{{tp|p=32701376|t=2020. Analysis of prediction and early warning indexes of patients with COVID-19.|pdf=|usr=}}
{{tp|p=32710533|t=2020. Pediatric Coronavirus Disease-19 (COVID-19): Meta-analyzing Literature Versus Natural History.|pdf=|usr=}}
{{tp|p=32697030|t=2020. Beneficial effect of awake prone position in hypoxaemic patients with COVID-19: case reports and literature review.|pdf=|usr=}}
{{tp|p=32710973|t=2020. Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.|pdf=|usr=}}
{{tp|p=32674221|t=2020. Comment on: COVID-19 and Older Adults: What We Know.|pdf=|usr=}}
{{tp|p=32662571|t=2020. Opportunities for Biomaterials to Address the Challenges of COVID-19.|pdf=|usr=}}
{{tp|p=32686993|t=2020. Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants.|pdf=|usr=}}
{{tp|p=32717771|t=2020. Role of extracorporeal membrane oxygenation in COVID-19: A systematic review.|pdf=|usr=}}
{{tp|p=32678961|t=2020. Extracorporeal membrane oxygenation and COVID-19: The causes of failure.|pdf=|usr=}}
{{tp|p=32668041|t=2020. COVID-19 patient bridged to recovery with veno-venous extracorporeal membrane oxygenation.|pdf=|usr=}}
{{tp|p=32660309|t=2020. COVID-19: A Review for the Pediatric Neurologist.|pdf=|usr=}}
{{tp|p=32675738|t=2020. Exercise, nutrition, and medication considerations in the light of the COVID pandemic, with specific focus on geriatric population: A literature review.|pdf=|usr=}}
{{tp|p=32703894|t=2020. The COVID-19 Diagnostic Dilemma: a Clinician's Perspective.|pdf=|usr=}}
{{tp|p=32703893|t=2020. My Experience with SARS-CoV-2, with a Focus on Testing.|pdf=|usr=}}
{{tp|p=32703888|t=2020. What Is Needed for the Response to COVID-19? A Micro-Comic Strip.|pdf=|usr=}}
{{tp|p=32643436|t=2020. Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19.|pdf=|usr=}}
{{tp|p=32666676|t=2020. The use of mechanistic reasoning in assessing coronavirus interventions.|pdf=|usr=}}
{{tp|p=32677498|t=2020. The Ventilator Management Team: Repurposing Anesthesia Workstations and Personnel to Combat COVID-19.|pdf=|usr=}}
{{tp|p=32700681|t=2020. Treating COVID-19: Review of drug hypersensitivity reactions.|pdf=|usr=}}
{{tp|p=32710639|t=2020. A Structural Equation Model to Examine the Clinical Features of Mild-to-Moderate Covid-19: A Multicenter Italian Study.|pdf=|usr=}}
{{tp|p=32706390|t=2020. The mechanistic rationale of drugs, Primary endpoints, Geographical distribution of clinical trials against Severe acute respiratory syndrome-related coronavirus-2: A Systematic Review.|pdf=|usr=}}
{{tp|p=32667699|t=2020. Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.|pdf=|usr=}}

PMC7352085 1. Improving the care of older patients during the COVID-19 pandemic.

Aging Clin Exp Res 2020; ä (ä): ä

*32654005*
                       32654005

PMC7338700 2. Expert consensus on protocol of rehabilitation for COVID-19 patients using framework and approaches of WHO International Family Classifications.

Aging Med (Milton) 2020; 3 (2): 82-94

*32666026*
                       32666026

PMC7347356 3. Propofol in COVID 19 - From basic science to clinical impact.

Am J Emerg Med 2020; ä (ä): ä

*32712236*
                       32712236

PMC7354274 4. Consistency and reliability of COVID-19 projection models as a means to save lives.

Am J Emerg Med 2020; ä (ä): ä

*32713604*
                       32713604

PMC7375183 5. The Down Side of Prone Positioning: The Case of a COVID-19 Survivor.

Am J Phys Med Rehabil 2020; ä (ä): ä

*32657818*
                       32657818

PMC7351041 6. No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients.

Anaesth Crit Care Pain Med 2020; ä (ä): ä

*32659455*
                       32659455

7. Evaluation and follow-up of pediatric COVID-19 in terms of cardiac involvement: A scientific statement from the Association of Turkish Pediatric Cardiology and Pediatric Cardiac Surgery.

Anatol J Cardiol 2020; 24 (1): 13-18

*32628134*
                       32628134

PMC7373363 8. In Response: The Use of Analgesia and Sedation in Mechanically Ventilated Patients with COVID-19 ARDS.

Anesth Analg 2020; ä (ä): ä

*32675641*
                       32675641

9. Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19.

Ann Palliat Med 2020; ä (ä): ä

*32692228*
                       32692228

PMC7366119 10. Extracorporeal Membrane Oxygenation Support in Severe COVID-19.

Ann Thorac Surg 2020; ä (ä): ä

*32687823*
                       32687823

PMC7318974 11. Mechanical Risks of Ventilator Sharing in the COVID-19 Era: A Simulation-Based Study.

Arch Bronconeumol 2020; ä (ä): ä

*32682580*
                       32682580

PMC7318980 12. Biologic Therapy in COVID-19.

Arch Bronconeumol 2020; ä (ä): ä

*32654852*
                       32654852

PMC7369467 13. A putative AOP for pneumonia related to COVID-19.

Arch Toxicol 2020; ä (ä): ä

*32691074*
                       32691074

PMC7368117 14. COVID-19 and Medical Biotechnology.

Avicenna J Med Biotechnol 2020; 12 (3): 139

*32695275*
                       32695275

PMC7347420 15. Machine learning to assist clinical decision-making during the COVID-19 pandemic.

Bioelectron Med 2020; 6 (ä): 14

*32665967*
                       32665967

PMC7369540 16. Management of Respiratory Distress Syndrome due to COVID-19 infection.

BMC Anesthesiol 2020; 20 (1): 177

*32689937*
                       32689937

PMC7360478 17. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.

BMC Med 2020; 18 (1): 215

*32664944*
                       32664944

PMC7373637 18. Update to living systematic review on prediction models for diagnosis and prognosis of covid-19.

BMJ 2020; 370 (ä): m2810

*32694132*
                       32694132

PMC7330564 19. Interdependence between elevated intra-abdominal, pleural, and airway opening pressure in severe acute respiratory distress syndrome with extracorporeal membrane oxygenation.

Br J Anaesth 2020; ä (ä): ä

*32682550*
                       32682550

PMC7328571 20. Airway management lessons from case reports of negative outcomes. Comment on Br J Anaesth; 125: e168-70.

Br J Anaesth 2020; ä (ä): ä

*32680606*
                       32680606

21. COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives.

Brain Sci 2020; 10 (7): ä

*32698378*
                       32698378

PMC7333603 22. Management of COVID-19 in burns patients: The experience of a UK burn centre.

Burns 2020; ä (ä): ä

*32713829*
                       32713829

PMC7376353 23. The Basics of ARDS Mechanical Ventilatory Care for Cardiovascular Specialists.

Can J Cardiol 2020; ä (ä): ä

*32712309*
                       32712309

PMC7362846 24. "How I Do It: High Flow, Non-invasive ventilation and Awake (non-intubation) Proning in Covid-19 Patients with Respiratory Failure".

Chest 2020; ä (ä): ä

*32681847*
                       32681847

PMC7361047 25. Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment.

Chest 2020; ä (ä): ä

*32679237*
                       32679237

26. Evaluation and management of shock in patients with COVID-19.

Cleve Clin J Med 2020; ä (ä): ä

*32680896*
                       32680896

27. COVID-19: challenges and opportunities.

Clin Exp Emerg Med 2020; ä (ä): ä

*32683854*
                       32683854

28. Overview of Management of Children with COVID-19.

Clin Exp Pediatr 2020; ä (ä): ä

*32683801*
                       32683801

PMC7374002 29. COVID-19 in children: reasons for uneventful clinical course.

Clin Exp Pediatr 2020; 63 (7): 237-238

*32664708*
                       32664708

PMC7385799 30. NEWS2 system requires modification to identify deteriorating patients with COVID-19.

Clin Med (Lond) 2020; 20 (4): e133-e134

*32675168*
                       32675168

PMC7385781 31. Research in brief: Prone positioning in COVID-19: What's the evidence.

Clin Med (Lond) 2020; 20 (4): 369

*32675139*
                       32675139

PMC7331556 32. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.

Clin Microbiol Infect 2020; ä (ä): ä

*32622952*
                       32622952

PMC7339477 33. Non Pharmaceutical Interventions for Optimal Control of COVID-19.

Comput Methods Programs Biomed 2020; 196 (ä): 105642

*32688137*
                       32688137

34. Initiation of Antiviral Treatment in SARS-CoV2: Modeling Viral Dynamics and Drug Properties.

CPT Pharmacometrics Syst Pharmacol 2020; ä (ä): ä

*32700405*
                       32700405

PMC7369442 35. Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance.

Crit Care 2020; 24 (1): 447

*32684170*
                       32684170

PMC7364297 36. Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study.

Crit Care 2020; 24 (1): 438

*32678040*
                       32678040

PMC7358559 37. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome.

Crit Care 2020; 24 (1): 428

*32665007*
                       32665007

PMC7335244 38. Data mining and analysis of scientific research data records on Covid-19 mortality, immunity, and vaccine development - In the first wave of the Covid-19 pandemic.

Diabetes Metab Syndr 2020; 14 (5): 1121-1132

*32659695*
                       32659695

PMC7361103 39. A novel scoring system in mortality prediction of severe patients with COVID-19.

EClinicalMedicine 2020; 24 (ä): 100450

*32691020*
                       32691020

PMC7357272 40. Proning reduces ventilation heterogeneity in patients with elevated BMI: implications for COVID-19 pneumonia management?

ERJ Open Res 2020; 6 (2): ä

*32685437*
                       32685437

PMC7335839 41. COVID-19 necrotising pneumonia and extracorporeal membrane oxygenation: a challenge for anticoagulation.

ERJ Open Res 2020; 6 (2): ä

*32665949*
                       32665949

PMC7321044 42. First comes the A, then the B: what we learned from the COVID-19 outbreak.

Eur J Intern Med 2020; ä (ä): ä

*32620500*
                       32620500

PMC7346840 43. Published evidence on COVID-19 in top-ranked journals: A descriptive study.

Eur J Intern Med 2020; ä (ä): ä

*32665174*
                       32665174

PMC7362854 44. COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus.

Eur J Med Chem 2020; 203 (ä): 112647

*32693298*
                       32693298

PMC7366121 45. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.

Eur J Pharmacol 2020; ä (ä): 173375

*32682788*
                       32682788

PMC7377211 46. COVID-19 prediction models should adhere to methodological and reporting standards.

Eur Respir J 2020; ä (ä): ä

*32703773*
                       32703773

PMC7366175 47. Awake Prone Positioning for Non-intubated Oxygen Dependent COVID-19 Pneumonia Patients.

Eur Respir J 2020; ä (ä): ä

*32675213*
                       32675213

PMC7366182 48. COVID-19 conundrum: Clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness.

Eur Respir J 2020; ä (ä): ä

*32675212*
                       32675212

PMC7366179 49. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study.

Eur Respir J 2020; ä (ä): ä

*32675205*
                       32675205

PMC7263061 50. The perils of premature phenotyping in COVID-19: a call for caution.

Eur Respir J 2020; 56 (1): ä

*32482788*
                       32482788

PMC7241108 51. A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019.

Eur Respir J 2020; 56 (1): ä

*32430433*
                       32430433

PMC7358282 52. Comment on: "Care for critically ill patients with COVID-19: don't forget the eyes".

Eye (Lond) 2020; ä (ä): ä

*32661338*
                       32661338

PMC7351482 53. From Farm to Finger Prick-A Perspective on How Plants Can Help in the Fight Against COVID-19.

Front Bioeng Biotechnol 2020; 8 (ä): 782

*32714921*
                       32714921

PMC7376071 54. COVID-19 in Different Age Groups of Children: Initial Impression from Integrated Disease Surveillance Programme (IDSP) under National Centre for Disease Control (NCDC).

Indian J Pediatr 2020; ä (ä): ä

*32700145*
                       32700145

55. Epidemiology and Clinical Features of Coronavirus Disease 2019 in Moroccan Children.

Indian Pediatr 2020; ä (ä): ä

*32651306*
                       32651306

56. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.

Int J Mol Sci 2020; 21 (14): ä

*32708196*
                       32708196

57. COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis.

Int J Mol Sci 2020; 21 (14): ä

*32708112*
                       32708112

PMC7381417 58. Integrating the evidence: confronting the COVID-19 elephant.

Intensive Care Med 2020; ä (ä): ä

*32710146*
                       32710146

PMC7378303 59. Therapie schwerer COVID-19-Verlaufe in der Intensivmedizin.

Internist (Berl) 2020; ä (ä): ä

*32710161*
                       32710161

PMC7376823 60. Die Virologie von SARS-CoV-2.

Internist (Berl) 2020; ä (ä): ä

*32705298*
                       32705298

PMC7375283 61. Interleukin-6-based mortality risk model for hospitalised COVID-19 patients.

J Allergy Clin Immunol 2020; ä (ä): ä

*32710975*
                       32710975

PMC7379972 62. No protocol and no liability: a call for COVID crisis guidelines that protect vulnerable populations.

J Comp Eff Res 2020; ä (ä): ä

*32705880*
                       32705880

PMC7384553 63. Primary Care Population Management for COVID-19 Patients.

J Gen Intern Med 2020; ä (ä): ä

*32720239*
                       32720239

64. Cultivating a Better Understanding of COVID-19 Amidst a Shifting Landscape.

Acad Emerg Med 2020; ä (ä): ä

*32717144*
                       32717144

65. Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients.

Am J Epidemiol 2020; ä (ä): ä

*32685980*
                       32685980

66. RE: EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED-UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS.

Am J Epidemiol 2020; ä (ä): ä

*32685975*
                       32685975

67. Commentary: Comment on "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis".

Am J Epidemiol 2020; ä (ä): ä

*32685969*
                       32685969

68. Response to: "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients" and "Re: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis".

Am J Epidemiol 2020; ä (ä): ä

*32685966*
                       32685966

69. Response to: Comment on "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients That Should be Ramped-Up Immediately as Key to the Pandemic Crisis".

Am J Epidemiol 2020; ä (ä): ä

*32685962*
                       32685962

70. Recommendations for caring for patients with severe and nonsevere COVID-19.

Ann Intern Med 2020; 173 (2): JC3

*32687760*
                       32687760

71. COVID-19: minimising contaminated aerosol spreading during CPAP treatment.

Arch Dis Child Fetal Neonatal Ed 2020; ä (ä): ä

*32669360*
                       32669360

72. SARS-CoV-2; What We Know so far.

Arch Iran Med 2020; 23 (7): 498-502

*32657601*
                       32657601

73. Specific considerations for venovenous-extracorporeal membrane oxygenation during Coronavirus Disease-2019 pandemic.

ASAIO J 2020; ä (ä): ä

*32701627*
                       32701627

74. Coronavirus disease 2019 pandemic and identifying insufflators with desufflation mode and surgical smoke evacuators for safe CO2 removal.

Asian J Endosc Surg 2020; ä (ä): ä

*32715659*
                       32715659

75. Comprehensive Review on Current Interventions, Diagnostic, and Nanotechnology Perspectives against SARS-CoV-2.

Bioconjug Chem 2020; ä (ä): ä

*32680422*
                       32680422

76. Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool.

BMJ 2020; 370 (ä): m2911

*32690476*
                       32690476

77. Covid-19: What do we know about "long covid"?

BMJ 2020; 370 (ä): m2815

*32665317*
                       32665317

78. The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy.

Chem Biol Drug Des 2020; ä (ä): ä

*32654267*
                       32654267

79. Simple 'Rule-of-6' predicts severe COVID-19 disease.

Clin Infect Dis 2020; ä (ä): ä

*32628752*
                       32628752

80. Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality.

Clin Infect Dis 2020; ä (ä): ä

*32674129*
                       32674129

81. Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions.

Curr Med Chem 2020; ä (ä): ä

*32651959*
                       32651959

82. A Case Study: Analysis of Patents of Coronaviruses and Covid-19 for Technology Assesment and Future Research.

Curr Pharm Des 2020; ä (ä): ä

*32693757*
                       32693757

83. COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy

Curr Pharm Des 2020; ä (ä): ä

*32660401*
                       32660401

84. COVID-19: making the right diagnosis.

Diagnosis (Berl) 2020; ä (ä): ä

*32651978*
                       32651978

85. Emerging pathogens and COVID-19: A brief introduction.

Dis Mon 2020; ä (ä): 101048

*32713542*
                       32713542

86. Prone Positioning in Non-intubated Patients with COVID-19 Outside the Intensive Care Unit: More Evidence Needed.

Disaster Med Public Health Prep 2020; ä (ä): 1-6

*32713387*
                       32713387

87. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.

DNA Cell Biol 2020; ä (ä): ä

*32716648*
                       32716648

88. Evidence-based medicine and COVID-19: what to believe and when to change.

Emerg Med J 2020; ä (ä): ä

*32651176*
                       32651176

89. Integrative role of traditional and modern technologies to combat COVID-19.

Expert Rev Anti Infect Ther 2020; ä (ä): ä

*32703036*
                       32703036

90. Emerging technologies for diagnostics and drug delivery in the fight against COVID-19 and other pandemics.

Expert Rev Med Devices 2020; ä (ä): 1-6

*32674622*
                       32674622

91. Analysis of prediction and early warning indexes of patients with COVID-19.

Expert Rev Respir Med 2020; ä (ä): 1-4

*32701376*
                       32701376

92. Pediatric Coronavirus Disease-19 (COVID-19): Meta-analyzing Literature Versus Natural History.

Indian Pediatr 2020; ä (ä): ä

*32710533*
                       32710533

93. Beneficial effect of awake prone position in hypoxaemic patients with COVID-19: case reports and literature review.

Intern Med J 2020; ä (ä): ä

*32697030*
                       32697030

94. Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.

J Allergy Clin Immunol 2020; ä (ä): ä

*32710973*
                       32710973

95. Comment on: COVID-19 and Older Adults: What We Know.

J Am Geriatr Soc 2020; ä (ä): ä

*32674221*
                       32674221

96. Opportunities for Biomaterials to Address the Challenges of COVID-19.

J Biomed Mater Res A 2020; ä (ä): ä

*32662571*
                       32662571

97. Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants.

J Biomol Struct Dyn 2020; ä (ä): 1-23

*32686993*
                       32686993

98. Role of extracorporeal membrane oxygenation in COVID-19: A systematic review.

J Card Surg 2020; ä (ä): ä

*32717771*
                       32717771

99. Extracorporeal membrane oxygenation and COVID-19: The causes of failure.

J Card Surg 2020; ä (ä): ä

*32678961*
                       32678961

100. COVID-19 patient bridged to recovery with veno-venous extracorporeal membrane oxygenation.

J Card Surg 2020; ä (ä): ä

*32668041*
                       32668041

101. COVID-19: A Review for the Pediatric Neurologist.

J Child Neurol 2020; ä (ä): 883073820939387

*32660309*
                       32660309

102. Exercise, nutrition, and medication considerations in the light of the COVID pandemic, with specific focus on geriatric population: A literature review.

J Chin Med Assoc 2020; ä (ä): ä

*32675738*
                       32675738

PMC7383561 103. The COVID-19 Diagnostic Dilemma: a Clinician's Perspective.

J Clin Microbiol 2020; 58 (8): ä

*32703894*
                       32703894

PMC7383536 104. My Experience with SARS-CoV-2, with a Focus on Testing.

J Clin Microbiol 2020; 58 (8): ä

*32703893*
                       32703893

PMC7383553 105. What Is Needed for the Response to COVID-19? A Micro-Comic Strip.

J Clin Microbiol 2020; 58 (8): ä

*32703888*
                       32703888

106. Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19.

J Drug Target 2020; ä (ä): 1-13

*32643436*
                       32643436

107. The use of mechanistic reasoning in assessing coronavirus interventions.

J Eval Clin Pract 2020; ä (ä): ä

*32666676*
                       32666676

108. The Ventilator Management Team: Repurposing Anesthesia Workstations and Personnel to Combat COVID-19.

J Intensive Care Med 2020; 35 (9): 927-932

*32677498*
                       32677498

109. Treating COVID-19: Review of drug hypersensitivity reactions.

J Investig Allergol Clin Immunol 2020; ä (ä): ä

*32700681*
                       32700681

110. A Structural Equation Model to Examine the Clinical Features of Mild-to-Moderate Covid-19: A Multicenter Italian Study.

J Med Virol 2020; ä (ä): ä

*32710639*
                       32710639

111. The mechanistic rationale of drugs, Primary endpoints, Geographical distribution of clinical trials against Severe acute respiratory syndrome-related coronavirus-2: A Systematic Review.

J Med Virol 2020; ä (ä): ä

*32706390*
                       32706390

112. Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.

J Med Virol 2020; ä (ä): ä

*32667699*
                       32667699


{{tp|p=32691016|t=2020. Why lockdown? Why national unity? Why global solidarity? Simplified arithmetic tools for decision-makers, health professionals, journalists and the general public to explore containment options for the 2019 novel coronavirus.|pdf=|usr=}}
{{tp|p=32690096|t=2020. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.|pdf=|usr=}}
{{tp|p=32617010|t=2020. Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32692258|t=2020. Extracorporeal Membrane Oxygenation for COVID-19.|pdf=|usr=}}
{{tp|p=32679328|t=2020. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.|pdf=|usr=}}
{{tp|p=32674450|t=2020. Clinical Presentation of COVID-19: Case Series and Review of the Literature.|pdf=|usr=}}
{{tp|p=32668763|t=2020. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=}}
{{tp|p=32702415|t=2020. Epidemiological and Clinical Characteristics of Coronavirus Disease 2019 in Daegu, South Korea.|pdf=|usr=}}
{{tp|p=32663601|t=2020. Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge.|pdf=|usr=}}
{{tp|p=32714083|t=2020. Advances and challenges in the prevention and treatment of COVID-19.|pdf=|usr=}}
{{tp|p=32714077|t=2020. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.|pdf=|usr=}}
{{tp|p=32699915|t=2020. Efficacy of early prone position for COVID-19 patients with severe hypoxia: a single-center prospective cohort study.|pdf=|usr=}}
{{tp|p=32671470|t=2020. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.|pdf=|usr=}}
{{tp|p=32654006|t=2020. Emerging pharmacological therapies for ARDS: COVID-19 and beyond.|pdf=|usr=}}
{{tp|p=32622261|t=2020. Current Status of COVID-19 Therapies and Drug Repositioning Applications.|pdf=|usr=}}
{{tp|p=32661197|t=2020. The molecular virology of Coronaviruses.|pdf=|usr=}}
{{tp|p=32696838|t=2020. Should all COVID-19 patients be approached in the same way?|pdf=|usr=}}
{{tp|p=32696835|t=2020. COVID-19 pandemic and mechanical ventilation: facing the present, designing the future.|pdf=|usr=}}
{{tp|p=32661797|t=2020. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=32674306|t=2020. Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris.|pdf=|usr=}}
{{tp|p=32683213|t=2020. Limiting positive end-expiratory pressure to protect renal function in SARS-CoV-2 critically ill patients.|pdf=|usr=}}
{{tp|p=32671115|t=2020. The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention.|pdf=|usr=}}
{{tp|p=32683343|t=2020. Improving the early diagnosis of suspected patients with COVID-19: a retrospective study of 106 patients.|pdf=|usr=}}
{{tp|p=32684351|t=2020. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.|pdf=|usr=}}
{{tp|p=32682658|t=2020. Comparing Chinese children and adults with RT-PCR positive COVID-19: A systematic review.|pdf=|usr=}}
{{tp|p=32715674|t=2020. Do We Really Need to Isolate All Children with COVID-19 in Healthcare Facilities?|pdf=|usr=}}
{{tp|p=32696264|t=2020. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.|pdf=|usr=}}
{{tp|p=32681989|t=2020. Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with COVID-19 in New York City.|pdf=|usr=}}
{{tp|p=32695427|t=2020. Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective.|pdf=|usr=}}
{{tp|p=32657586|t=2020. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.|pdf=|usr=}}
{{tp|p=32654489|t=2020. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.|pdf=|usr=}}
{{tp|p=32703914|t=2020. COVID-19 from the Perspective of a Gastroenterologist.|pdf=|usr=}}
{{tp|p=32687919|t=2020. A lung for all: Novel mechanical ventilator for emergency and low-resource settings.|pdf=|usr=}}
{{tp|p=32687917|t=2020. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32629670|t=2020. Failure of early extubation among cases of coronavirus disease-19 respiratory failure: Case report and clinical experience.|pdf=|usr=}}
{{tp|p=32670520|t=2020. Children in Coronaviruses' Wonderland: What Clinicians Need to Know.|pdf=|usr=}}
{{tp|p=32681968|t=2020. Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis.|pdf=|usr=}}
{{tp|p=32707942|t=2020. Evaluation of Current Therapies for COVID-19 Treatment.|pdf=|usr=}}
{{tp|p=32671688|t=2020. Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics.|pdf=|usr=}}
{{tp|p=32669540|t=2020. Early triage of critically ill COVID-19 patients using deep learning.|pdf=|usr=}}
{{tp|p=32671650|t=2020. SARS-CoV-2/COVID-19: a primer for cardiologists.|pdf=|usr=}}
{{tp|p=32622086|t=2020. Neurobiology of coronaviruses: Potential relevance for COVID-19.|pdf=|usr=}}
{{tp|p=32670592|t=2020. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.|pdf=|usr=}}
{{tp|p=32695885|t=2020. Estimating the efficacy of symptom-based screening for COVID-19.|pdf=|usr=}}
{{tp|p=32661497|t=2020. An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=}}
{{tp|p=32677509|t=2020. The Palliative Performance Scale predicts mortality in hospitalized patients with COVID-19.|pdf=|usr=}}
{{tp|p=32621013|t=2020. Management strategies for children with COVID-19: ESPR practical recommendations.|pdf=|usr=}}
{{tp|p=32656001|t=2020. Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios.|pdf=|usr=}}
{{tp|p=32706941|t=2020. Agitation Management During the COVID-19 Pandemic: The Time for a Noncoercive Approach Is Now.|pdf=|usr=}}
{{tp|p=32678526|t=2020. Weaning From Exogenous Sedation in the Era of COVID-19 Infection: Recommendations for Sedation and Its Discontinuation.|pdf=|usr=}}
{{tp|p=32673191|t=2020. Racial/Ethnic Disparities in Disease Severity on Admission Chest Radiographs among Patients Admitted with Confirmed COVID-19: A Retrospective Cohort Study.|pdf=|usr=}}
{{tp|p=32653383|t=2020. Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020.|pdf=|usr=}}
{{tp|p=32698822|t=2020. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19.|pdf=|usr=}}
{{tp|p=32684644|t=2020. COVID-19: a short message to rheumatologists.|pdf=|usr=}}
{{tp|p=32667444|t=2020. Diretrizes para o tratamento farmacologico da COVID-19. Consenso da Associacao de Medicina Intensiva Brasileira, da Sociedade Brasileira de Infectologia e da Sociedade Brasileira de Pneumologia e Tisiologia.|pdf=|usr=}}
{{tp|p=32660623|t=2020. National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study.|pdf=|usr=}}
{{tp|p=32699587|t=2020. SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer.|pdf=|usr=}}
{{tp|p=32669846|t=2020. Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review.|pdf=|usr=}}
{{tp|p=32651761|t=2020. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.|pdf=|usr=}}
{{tp|p=32658053|t=2020. COVID-19 Trials and Tribulations by Rebecca Gliksman MD MPH.|pdf=|usr=}}
{{tp|p=32686937|t=2020. SARS-CoV-2 encoded proteome and human genetics: from interaction-based to ribosomal biology impact on disease and risk processes.|pdf=|usr=}}
{{tp|p=32673407|t=2020. In Response to Anosmia and Ageusia: Common Findings in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32673402|t=2020. In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32677734|t=2020. Clinical presentation and management of COVID-19.|pdf=|usr=}}
{{tp|p=32651579|t=2020. Extrapulmonary manifestations of COVID-19.|pdf=|usr=}}
{{tp|p=32694872|t=2020. Five coronavirus questions scientists still don't have answers to.|pdf=|usr=}}
{{tp|p=32674170|t=2020. Pediatric COVID-19 Disease: A Review of the Recent Literature.|pdf=|usr=}}
{{tp|p=32710693|t=2020. Insight into the Pediatric and Adult Dichotomy of COVID-19: Age-Related Differences in the Immune Response to SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32710652|t=2020. Children and COVID-19: Microbiological and immunological insights.|pdf=|usr=}}
{{tp|p=32712625|t=2020. Shoring up the safety net for children in the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32679582|t=2020. A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children.|pdf=|usr=}}
{{tp|p=32665373|t=2020. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy.|pdf=|usr=}}
{{tp|p=32663611|t=2020. Data to guide the application of the new WHO criteria for releasing COVID-19 patients from isolation.|pdf=|usr=}}
{{tp|p=32691056|t=2020. Prone Positioning of Patients With Acute Respiratory Distress Syndrome Related to COVID-19: A Rehabilitation-Based Prone Team.|pdf=|usr=}}
{{tp|p=32674191|t=2020. ECMO als Therapie des schweren Lungenversagens bei COVID-19.|pdf=|usr=}}
{{tp|p=32674190|t=2020. 48-jahriger Triathlet mit schwerer COVID-19-Pneumonie: erfolgreiche und sichere Behandlung mit Sauerstoff und CPAP.|pdf=|usr=}}
{{tp|p=32692813|t=2020. Use of External Ventilator Control Panel for Mechanical Ventilation in Patients with Severe SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=32652021|t=2020. Association of Padua prediction score with in-hospital prognosis in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32713937|t=2020. Covid-19 y salud infantil: el confinamiento y su impacto segun profesionales de la infancia.|pdf=|usr=}}

PMC7342051 113. Why lockdown? Why national unity? Why global solidarity? Simplified arithmetic tools for decision-makers, health professionals, journalists and the general public to explore containment options for the 2019 novel coronavirus.

Infect Dis Model 2020; 5 (ä): 442-458

*32691016*
                       32691016

PMC7369569 114. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.

Infect Dis Poverty 2020; 9 (1): 99

*32690096*
                       32690096

PMC7326396 115. Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients.

Infect Drug Resist 2020; 13 (ä): 1995-2000

*32617010*
                       32617010

116. Extracorporeal Membrane Oxygenation for COVID-19.

Innovations (Phila) 2020; ä (ä): 1556984520937821

*32692258*
                       32692258

PMC7358770 117. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.

Int J Biol Macromol 2020; 164 (ä): 331-343

*32679328*
                       32679328

118. Clinical Presentation of COVID-19: Case Series and Review of the Literature.

Int J Environ Res Public Health 2020; 17 (14): ä

*32674450*
                       32674450

119. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.

Int J Environ Res Public Health 2020; 17 (14): ä

*32668763*
                       32668763

PMC7371586 120. Epidemiological and Clinical Characteristics of Coronavirus Disease 2019 in Daegu, South Korea.

Int J Infect Dis 2020; ä (ä): ä

*32702415*
                       32702415

121. Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge.

Int J Infect Dis 2020; ä (ä): ä

*32663601*
                       32663601

PMC7378666 122. Advances and challenges in the prevention and treatment of COVID-19.

Int J Med Sci 2020; 17 (12): 1803-1810

*32714083*
                       32714083

PMC7378653 123. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.

Int J Med Sci 2020; 17 (12): 1744-1750

*32714077*
                       32714077

PMC7375455 124. Efficacy of early prone position for COVID-19 patients with severe hypoxia: a single-center prospective cohort study.

Intensive Care Med 2020; ä (ä): ä

*32699915*
                       32699915

PMC7362315 125. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.

Intensive Care Med 2020; ä (ä): ä

*32671470*
                       32671470

PMC7352097 126. Emerging pharmacological therapies for ARDS: COVID-19 and beyond.

Intensive Care Med 2020; ä (ä): ä

*32654006*
                       32654006

PMC7305759 127. Current Status of COVID-19 Therapies and Drug Repositioning Applications.

iScience 2020; 23 (7): 101303

*32622261*
                       32622261

128. The molecular virology of Coronaviruses.

J Biol Chem 2020; ä (ä): ä

*32661197*
                       32661197

129. Should all COVID-19 patients be approached in the same way?

J Bras Pneumol 2020; 46 (4): e20200218

*32696838*
                       32696838

130. COVID-19 pandemic and mechanical ventilation: facing the present, designing the future.

J Bras Pneumol 2020; 46 (4): e20200282

*32696835*
                       32696835

PMC7357264 131. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.

J Clin Immunol 2020; ä (ä): ä

*32661797*
                       32661797

132. Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris.

J Clin Med 2020; 9 (7): ä

*32674306*
                       32674306

PMC7348607 133. Limiting positive end-expiratory pressure to protect renal function in SARS-CoV-2 critically ill patients.

J Crit Care 2020; 59 (ä): 191-193

*32683213*
                       32683213

PMC7352127 134. The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention.

J Immunol Res 2020; 2020 (ä): 1357983

*32671115*
                       32671115

135. Improving the early diagnosis of suspected patients with COVID-19: a retrospective study of 106 patients.

J Infect Dev Ctries 2020; 14 (6): 547-553

*32683343*
                       32683343

PMC7357519 136. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.

J Infect Public Health 2020; ä (ä): ä

*32684351*
                       32684351

PMC7357530 137. Comparing Chinese children and adults with RT-PCR positive COVID-19: A systematic review.

J Infect Public Health 2020; ä (ä): ä

*32682658*
                       32682658

PMC7384904 138. Do We Really Need to Isolate All Children with COVID-19 in Healthcare Facilities?

J Korean Med Sci 2020; 35 (29): e277

*32715674*
                       32715674

PMC7373339 139. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.

J Neuroimmune Pharmacol 2020; ä (ä): ä

*32696264*
                       32696264

PMC7363610 140. Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with COVID-19 in New York City.

J Pediatr 2020; ä (ä): ä

*32681989*
                       32681989

PMC7366879 141. Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective.

J Pharm Policy Pract 2020; 13 (ä): 45

*32695427*
                       32695427

PMC7384384 142. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.

J Proteome Res 2020; ä (ä): ä

*32657586*
                       32657586

PMC7384389 143. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.

J Proteome Res 2020; ä (ä): ä

*32654489*
                       32654489

144. COVID-19 from the Perspective of a Gastroenterologist.

Korean J Gastroenterol 2020; 76 (1): 4-8

*32703914*
                       32703914

PMC7366115 145. A lung for all: Novel mechanical ventilator for emergency and low-resource settings.

Life Sci 2020; 257 (ä): 118113

*32687919*
                       32687919

PMC7366108 146. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.

Life Sci 2020; 257 (ä): 118105

*32687917*
                       32687917

PMC7337554 147. Failure of early extubation among cases of coronavirus disease-19 respiratory failure: Case report and clinical experience.

Medicine (Baltimore) 2020; 99 (27): e20843

*32629670*
                       32629670

PMC7340228 148. Children in Coronaviruses' Wonderland: What Clinicians Need to Know.

Mediterr J Hematol Infect Dis 2020; 12 (1): e2020042

*32670520*
                       32670520

PMC7361116 149. Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis.

Microb Pathog 2020; ä (ä): 104390

*32681968*
                       32681968

150. Evaluation of Current Therapies for COVID-19 Treatment.

Microorganisms 2020; 8 (8): ä

*32707942*
                       32707942

PMC7360695 151. Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics.

Mol Neurobiol 2020; ä (ä): ä

*32671688*
                       32671688

PMC7363899 152. Early triage of critically ill COVID-19 patients using deep learning.

Nat Commun 2020; 11 (1): 3543

*32669540*
                       32669540

PMC7360901 153. SARS-CoV-2/COVID-19: a primer for cardiologists.

Neth Heart J 2020; 28 (7-8): 366-383

*32671650*
                       32671650

PMC7329662 154. Neurobiology of coronaviruses: Potential relevance for COVID-19.

Neurobiol Dis 2020; 143 (ä): 105007

*32622086*
                       32622086

PMC7313508 155. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.

New Microbes New Infect 2020; 36 (ä): 100723

*32670592*
                       32670592

PMC7359358 156. Estimating the efficacy of symptom-based screening for COVID-19.

NPJ Digit Med 2020; 3 (ä): 95

*32695885*
                       32695885

PMC7313828 157. An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2.

Open Forum Infect Dis 2020; 7 (7): ofaa232

*32661497*
                       32661497

PMC7378312 158. The Palliative Performance Scale predicts mortality in hospitalized patients with COVID-19.

Palliat Med 2020; ä (ä): 269216320940566

*32677509*
                       32677509

PMC7332738 159. Management strategies for children with COVID-19: ESPR practical recommendations.

Pediatr Radiol 2020; ä (ä): ä

*32621013*
                       32621013

PMC7331623 160. Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios.

PeerJ 2020; 8 (ä): e9482

*32656001*
                       32656001

161. Agitation Management During the COVID-19 Pandemic: The Time for a Noncoercive Approach Is Now.

Prim Care Companion CNS Disord 2020; 22 (4): ä

*32706941*
                       32706941

162. Weaning From Exogenous Sedation in the Era of COVID-19 Infection: Recommendations for Sedation and Its Discontinuation.

Prim Care Companion CNS Disord 2020; 22 (4): ä

*32678526*
                       32678526

PMC7370353 163. Racial/Ethnic Disparities in Disease Severity on Admission Chest Radiographs among Patients Admitted with Confirmed COVID-19: A Retrospective Cohort Study.

Radiology 2020; ä (ä): 202602

*32673191*
                       32673191

PMC7321050 164. Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020.

Respir Investig 2020; ä (ä): ä

*32653383*
                       32653383

PMC7374662 165. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19.

Respir Res 2020; 21 (1): 194

*32698822*
                       32698822

PMC7362267 166. COVID-19: a short message to rheumatologists.

Reumatologia 2020; 58 (3): 130-133

*32684644*
                       32684644

167. Diretrizes para o tratamento farmacologico da COVID-19. Consenso da Associacao de Medicina Intensiva Brasileira, da Sociedade Brasileira de Infectologia e da Sociedade Brasileira de Pneumologia e Tisiologia.

Rev Bras Ter Intensiva 2020; 32 (2): 166-196

*32667444*
                       32667444

PMC7356106 168. National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study.

Scand J Trauma Resusc Emerg Med 2020; 28 (1): 66

*32660623*
                       32660623

PMC7357014 169. SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer.

Ther Adv Endocrinol Metab 2020; 11 (ä): 2042018820942385

*32699587*
                       32699587

PMC7335700 170. Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review.

Ther Clin Risk Manag 2020; 16 (ä): 595-605

*32669846*
                       32669846

PMC7348560 171. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.

Vet Res Commun 2020; ä (ä): ä

*32651761*
                       32651761

172. COVID-19 Trials and Tribulations by Rebecca Gliksman MD MPH.

J Occup Environ Med 2020; ä (ä): ä

*32658053*
                       32658053

173. SARS-CoV-2 encoded proteome and human genetics: from interaction-based to ribosomal biology impact on disease and risk processes.

J Proteome Res 2020; ä (ä): ä

*32686937*
                       32686937

174. In Response to Anosmia and Ageusia: Common Findings in COVID-19 Patients.

Laryngoscope 2020; ä (ä): ä

*32673407*
                       32673407

175. In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients.

Laryngoscope 2020; ä (ä): ä

*32673402*
                       32673402

176. Clinical presentation and management of COVID-19.

Med J Aust 2020; ä (ä): ä

*32677734*
                       32677734

177. Extrapulmonary manifestations of COVID-19.

Nat Med 2020; 26 (7): 1017-1032

*32651579*
                       32651579

178. Five coronavirus questions scientists still don't have answers to.

Nature 2020; ä (ä): ä

*32694872*
                       32694872

179. Pediatric COVID-19 Disease: A Review of the Recent Literature.

Pediatr Ann 2020; 49 (7): e319-e325

*32674170*
                       32674170

180. Insight into the Pediatric and Adult Dichotomy of COVID-19: Age-Related Differences in the Immune Response to SARS-CoV-2 infection.

Pediatr Pulmonol 2020; ä (ä): ä

*32710693*
                       32710693

181. Children and COVID-19: Microbiological and immunological insights.

Pediatr Pulmonol 2020; ä (ä): ä

*32710652*
                       32710652

182. Shoring up the safety net for children in the COVID-19 pandemic.

Pediatr Res 2020; ä (ä): ä

*32712625*
                       32712625

183. A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children.

Pediatr Res 2020; ä (ä): ä

*32679582*
                       32679582

184. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy.

Pediatrics 2020; ä (ä): ä

*32665373*
                       32665373

185. Data to guide the application of the new WHO criteria for releasing COVID-19 patients from isolation.

Pharmacol Res 2020; 160 (ä): 105063

*32663611*
                       32663611

186. Prone Positioning of Patients With Acute Respiratory Distress Syndrome Related to COVID-19: A Rehabilitation-Based Prone Team.

Phys Ther 2020; ä (ä): ä

*32691056*
                       32691056

187. ECMO als Therapie des schweren Lungenversagens bei COVID-19.

Pneumologie 2020; 74 (7): 423-428

*32674191*
                       32674191

188. 48-jahriger Triathlet mit schwerer COVID-19-Pneumonie: erfolgreiche und sichere Behandlung mit Sauerstoff und CPAP.

Pneumologie 2020; 74 (7): 417-422

*32674190*
                       32674190

189. Use of External Ventilator Control Panel for Mechanical Ventilation in Patients with Severe SARS-CoV-2 Infection.

QJM 2020; ä (ä): ä

*32692813*
                       32692813

190. Association of Padua prediction score with in-hospital prognosis in COVID-19 patients.

QJM 2020; ä (ä): ä

*32652021*
                       32652021

191. Covid-19 y salud infantil: el confinamiento y su impacto segun profesionales de la infancia.

Rev Esp Salud Publica 2020; 94 (ä): ä

*32713937*
                       32713937